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ABSTRACT
DDX3 is an RNA chaperone of the DEAD-box family
that regulates translation. Ded1, the yeast ortholog
of DDX3, is a global regulator of translation, whereas
DDX3 is thought to preferentially affect a subset of
mRNAs. However, the set of mRNAs that are regu-
lated by DDX3 are unknown, along with the relation-
ship between DDX3 binding and activity. Here, we
use ribosome profiling, RNA-seq, and PAR-CLIP to
define the set of mRNAs that are regulated by DDX3
in human cells. We find that while DDX3 binds highly
expressed mRNAs, depletion of DDX3 particularly af-
fects the translation of a small subset of the tran-
scriptome. We further find that DDX3 binds a site
on helix 16 of the human ribosomal rRNA, placing
it immediately adjacent to the mRNA entry channel.
Translation changes caused by depleting DDX3 lev-
els or expressing an inactive point mutation are dif-
ferent, consistent with different association of these
genetic variant types with disease. Taken together,
this work defines the subset of the transcriptome that
is responsive to DDX3 inhibition, with relevance for
basic biology and disease states where DDX3 is al-
tered.
INTRODUCTION
Translation initiation is affected by mRNA regulatory el-
ements. The DEAD-box RNA chaperone DDX3 and its
yeast ortholog Ded1 facilitate translation initiation on mR-
NAs with structured 5′ untranslated regions (UTRs) (1–
4), a function that is essential in all eukaryotes (5). Dys-
function in DDX3 is linked to numerous diseases, includ-
ing medulloblastoma (3,6–12), many other cancer types
(5) and de novo developmental delay (13–16). Previous
work studied how translation is altered by DDX3 variants
found in medulloblastoma (3,12), which are exclusively mis-
sense variants that preferentially target conserved residues.
In contrast, hematological cancers like natural killer/T-
cell lymphoma (17,18) and others (19,20) also have fre-
quent variants in DDX3X, but they are mostly truncat-
ing or frameshift variants resulting in decreased expression.
Changes in gene expression occurring as a result of de-
creased DDX3 levels remain incompletely understood.
Inactivation of Ded1 in yeast leads to polysome collapse
and global downregulation of translation (21,22). More re-
cent work showed that Ded1 is required for translation of
most transcripts in yeast using genome-wide approaches
(1,23). In contrast, DDX3 depletion seems to only affect
translation of a subset of expressed transcripts (2,4,24–26).
Despite the importance of DDX3 to normal function and
its alteration in diverse disease states, the set of genes that
depend on DDX3 for translation is not clearly defined.
Moreover, it has been challenging to relate DDX3 binding
to functional effects on bound mRNAs, and it was unclear
if DDX3 functions outside of translation initiation given
that binding was detected in coding sequences and 3′ UTRs
(3,12).
Here, we depleted DDX3 protein levels and measured al-
terations to translation and RNA abundance using ribo-
some profiling and RNA-seq. We also characterized DDX3
binding by PAR-CLIP, using the presence of T>C muta-
tions as a diagnostic hallmark of protein–RNA interac-
tions. We observed robust interactions between DDX3 and
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transcript 5′ UTRs, as well as a specific and conserved site
on the 18S ribosomal rRNA. We found that transcripts with
structured 5′ UTRs are preferentially affected by DDX3.
We used in vitro and cellular reporter systems to conclude
that decreases in ribosome occupancy upon DDX3 deple-
tion are driven by 5′ UTRs. Taken together, our results sup-
port a model for DDX3 function where interactions with
the small ribosomal subunit facilitate translation on mes-
sages with structured 5′ UTRs, which, when inactivated,
pathologically deregulates protein synthesis.
MATERIALS AND METHODS
NGS data pre-processing
Ribo-seq fastq files were stripped of the adapter sequences
using cutadapt. UMI sequences were removed and reads
were collapsed to fasta format. Reads were first aligned
against rRNA (accession number U13369.1), and to a col-
lection of snoRNAs, tRNAs and miRNA (retrieved using
the UCSC table browser) using bowtie2 (27) in the ‘local’
alignment mode.
Remaining reads were mapped to the hg38 version of the
genome (without scaffolds) using STAR 2.6.0a (28) sup-
plied with the GENCODE 32 .gtf file. A maximum of three
mismatches and mapping to a maximum of 50 positions was
allowed. De-novo splice junction discovery was disabled for
all datasets. Only the best alignment per each read was re-
tained. Read counts for all libraries are in Supplementary
Table S3.
PAR-CLIP peak calling
Peak calling for PAR-CLIP reads was performed with PAR-




MINIMUM READ COUNT PER GROUP = 5
MINIMUM READ COUNT PER CLUSTER = 5
MINIMUM READ COUNT FOR KDE = 5
MINIMUM CLUSTER SIZE = 8
MINIMUM CONVERSION LOCATIONS FOR CL
USTER = 1
MINIMUM CONVERSION COUNT FOR CLUSTER
= 3
MINIMUM READ COUNT FOR CLUSTER INCL
USION = 5
MINIMUM READ LENGTH = 18
MAXIMUM NUMBER OF NON CONVERSION MI
SMATCHES = 0
Peaks with >10 reads were retained for subsequent analysis.
Coverage-normalized T>C conversions on rRNA for po-
sitions with 2000 reads or more (Supplementary Figure
S4A) were mapped onto the 18S rRNA sequence from PDB
entry 6FEC and visualized using UCSF Chimera (30).
Differential expression analysis
Count matrices for Ribo-seq and RNA-seq were built using
reads mapping uniquely to CDS regions of protein-coding
genes, using the Bioconductor packages GenomicFeatures,
GenomicFiles and GenomicAlignments (31). Genomic and
transcript regions where extracted using Ribo-seQC (32).
Only reads mapping for more than 25nt were used.
Differential analysis was using DESeq2 (33). Concordant
changes were defined using an FDR cutoff of 0.01 for RNA-
seq and Ribo-seq individually and ensuring the same direc-
tionality in the estimated fold changes.
Changes in translation efficiency were calculated using
DESeq2 by using assay type (RNA-seq or Ribo-seq) as an
additional covariate. Translationally regulated genes were
defined using an FDR cutoff of 0.05 from a likelihood ra-
tio test, using a reduced model without the assay type co-
variate, e.g. assuming no difference between RNA-seq and
Ribo-seq counts (34).
For both RNA-seq and Ribo-seq, only genes with Base-
Mean >8 or more than the bottom 10% of the library
were used. GO enrichment analysis was performed with the
topGO package (version 2.38.1; available from BioConduc-
tor), using the Fisher test with default parameters.
The Random Forest regression was run using the ran-
domForest package (version 4.6-14; available from CRAN)
with default parameters. Lasso regression was performed
on scaled variables using the glmnet package (35). The fol-
lowing features for each gene were used:
• TPM values using RNA-seq (in log scale);
• Baseline TE levels, defined as ratio of Ribo to RNA reads;
• Baseline RNA mature levels, defined as length-
normalized ratio of RNA-seq reads in introns versus
exons;
• GC content, length (in log scale) and ribosome density in:
5′ UTRs, a window of 25nt around start and stop codons,
CDS regions, non-coding internal exons, introns, and 3′
UTRs;
• Additional sequence features, including density of motif
scores (calculated using the Biostrings package) for the
following motifs, partially taken from (36):
- TOP: a binary variable indicating if gene belongs to core
TOP mRNA, as defined in (37)
- PRTE(pyrimidine-rich translational element):
‘[CU][CU][CU][CU][U][CU][CU][CU]’
- TISU(Translator Initiator of Short 5′-UTR):
‘[CG][A][A][CG][A][U][G][G][C][G][G][C]’
- CERT (cytosine-enriched regulator of trans-
lation): ‘[CG][CGU][CGU][CG][CGU][C][CG
U][C][CA][GU][C][CGU][CGUA][CG][C]’
- PQS: propensity to create G quadruplexes, calculated us-
ing the pqsfinder R package (38)
Feature importance (measured by mean decrease in accu-
racy for the random forest model) and correlation between
predicted and measured test data were calculated on a 10-
fold cross-validation scheme.
Meta-transcript profiles
PARalyzer peaks (and peaks from the POSTAR2 repository
(39)) were mapped on transcript coordinates using one cod-
ing transcript per gene: such transcript was chosen to have
the longest 5′ UTR and the most common annotated start
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codon for that gene. Transcript positions were converted
into bins using 15 bins for each 5′ UTR, 30 bins for each
CDS and 20 bins for each 3′ UTR. Peak scores were nor-
malized for each transcript (to sum up to 1), and values were
summed for each bin to build aggregate profiles, as in Fig-
ure 4B. When plotting profiles for different RBPs. the aggre-
gate profiles were further normalized to a sum of 1. To build
the average meta-transcript profile in Figure 4C, conversion
specificity values were averaged per transcript bin. To cre-
ate shuffled profiles in Figure 4F and Supplementary Figure
S4, 5 random positions for each peak were taken from the
same bound UTR.
De novo motif finding
The STREME algorithm (40) was used to perform de novo
motif finding, using PAR-CLIP peaks from the POSTAR2
repository, selecting peaks from HEK 293 cells called with
PARalyzer as above, and selecting for peaks in UTRs and
intronic regions in protein-coding genes. The following pa-
rameters were used:
–rna –minw 5 –maxw 15 –pvt 0.05 –totallength 1e7 –time
18000 –patience 6
Additional transcript features analysis
To compare read mapping locations within transcripts, a
window of 25nt around the start codon was subtracted from
annotated 5′ UTRs and CDS. 5′ UTRs and CDS regions
in genomic and transcriptomic space were retrieved using
Ribo-seQC. Counts on 5′ UTR and CDS were first aver-
aged between replicates. The ratio 5′ UTR to CDS of these
counts were calculated for each gene, in the siRNA and con-
trols condition. The log2 of the ratio siDDX3/control for
those values represents the skew of counts towards 5′ UTR

















RNA in silico folding was performed on 5′ UTRs se-
quences using RNAlfold (41) with default parameters. Av-
erage G values per nucleotide were calculated averaging
the G values of each structure overlapping that nucleotide.
%GC content and T>C transition specificity (defined as
ConversionEventCount / (ConversionEventCount + Non-
ConversionEventCount)) for each PAR-CLIP peak were de-
rived using the clusters.csv output file from PARalyzer. Gviz
was used to plot tracks for RNA-seq, Ribo-seq and PAR-
CLIP over different transcripts. The Wilcoxon rank sum
was used for statistical testing and Cliff ’s delta was used to
calculate effect sizes as described (42).
Source code to reproduce figures can be found at:
https://github.com/lcalviell/DDX3X RPCLIP
Ribosome profiling
Knockdown RP: Flp-In T-REx HEK 293 cells transfected
with control siPool and with DDX3X-targeting siPools (two
replicates each, siTOOLs Biotech; sequences in Supplemen-
tary Table S5) were washed with PBS containing 100 g/ml
cycloheximide to trap ribosomes, flash frozen on liquid ni-
trogen, lysed in lysis buffer (20 mM Tris–HCl pH 7.4, 150
mM NaCl, 5 mM MgCl2 1% (v/v) Triton X-100, 25 U/ml
TurboDNase (Ambion), harvested, centrifuged at 20 000 g
for 4 min at 4◦C and supernatants were stored at –80◦C.
Thawed lysates were treated with RNase I (Ambion) at 2.5
U/l for 45 min at room temperature with slow agitation.
Further RNase activity was stopped by addition of SU-
PERase:In (Ambion). Next Illustra MicroSpin Columns S-
400 HR (GE Healthcare) were used to enrich for ribosome
complexes. RNA was extracted from column flow throughs
with TRIzol (Ambion) reagent. Precipitated nucleic acids
were further purified and concentrated with Zymo-Spin
IIC column (Zymo Research). Obtained RNA was depleted
of rRNAs with Ribo-Zero Gold Kit (Human/Mouse/Rat)
kit (Illumina), separated in 17% urea gel and stained with
SYBR Gold (Invitrogen). Gel slices containing nucleic acids
27–30 nucleotides long were excised and incubated in a ther-
momixer with 0.3 M NaCl at 4◦C overnight with constant
agitation to elute RNA. After precipitation nucleic acids
were treated with T4 polynucleotide kinase (Thermo Scien-
tific). Purified RNA was ligated to 3′ and 5′ adapters, reverse
transcribed and PCR amplified. The amplified cDNA was
sequenced on a HiSeq2000 (Illumina).
Degron RP: DDX3X-mAID tagged HCT 116 (one 15 cm
dish at 80–90% confluency per replicate, two replicates) cells
expressing OsTIR1 were transfected with either wild-type
DDX3X or DDX3X R326H. 24 hours post-transfection,
media was changed and fresh media with 500 M indole
3-acetic acid (IAA) was added to cells. Un-transfected cells
were treated with either DMSO or IAA. Forty-eight hours
after auxin addition, cells were treated with 100 g/ml cy-
cloheximide (CHX) for two minutes to trap ribosomes and
harvested and lysed as described in (43). Briefly, cells were
washed with PBS containing 100 g/ml CHX and lysed
in ice-cold lysis buffer (20 mM Tris–HCl pH 7.4, 150 mM
NaCl, 5 mM MgCl2, 1 mM DTT, 100 g/ml CHX, 1%
(v/v) Triton X-100, 25 U/ml TurboDNase (Ambion). 240
l lysate was treated with 6 l RNase I (Ambion, 100 U/l)
for 45 min at RT with gentle agitation and further diges-
tion halted by addition of SUPERase:In (Ambion). Illustra
Microspin Columns S-400 HR (GE healthcare) were used
to enrich for monosomes, and RNA was extracted from
the flow-through using Direct-zol kit (Zymo Research). Gel
slices of nucleic acids between 24 and 32 nts long were ex-
cised from a 15% urea–PAGE gel. Eluted RNA was treated
with T4 PNK and preadenylated linker was ligated to the 3′
end using T4 RNA Ligase 2 truncated KQ (NEB, M0373L).
Linker-ligated footprints were reverse transcribed using Su-
perscript III (Invitrogen) and gel-purified RT products cir-
cularized using CircLigase II (Lucigen, CL4115K). rRNA
depletion was performed using biotinylated oligos as de-
scribed in (44) and libraries constructed using a different
reverse indexing primer for each sample.
PAR-CLIP experiments
Flp-In T-REx HEK 293 cells expressing FLAG/HA-tagged
DDX3X (45) were labeled with 100 M 4-thiouridine for
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16h. PAR-CLIP was performed generally as described
(46,47). Briefly, cells were UV-crosslinked with 0.15 J/cm2
at 365 nm, and stored at –80◦C. Obtained cell pellets
were lysed in three times the cell pellet volume of NP-
40 lysis buffer (50 mM HEPES-KOH at pH 7.4, 150 mM
KCl, 2 mM EDTA, 1 mM NaF, 0.5% (v/v) NP-40, 0.5
mM DTT, complete EDTA-free protease inhibitor cock-
tail (Roche)), incubated 10 min on ice and centrifuged
at 13000 rpm for 15 min at 4◦C. Supernatants were fil-
tered through 5 m syringe filter. Next, lysates were treated
with RNase I (Thermo-Fisher Scientific) at final con-
centration of 0.25 U/l for 10 min at room tempera-
ture. Immunoprecipitation of the DDX3/RNA complexes
was performed with FLAG magnetic beads (Sigma). Af-
ter IP and washing, the protein-bound RNAs were 3′ de-
phosphorylated and 5′-end phosphorylated using T4 PNK
with 0.01% Triton X-100, and the NIR fluorescent adap-
tor (5′-OH-AGATCGGAAGAGCGGTTCAGAAAAAA
AAAAAA/iAzideN/AAAAAAAAAAAA/3Bio/-3′) was
ligated to the RNA using truncated RNA ligase 2 K227Q
(NEB) overnight at 16◦C, shaking at 1600 rpm. Crosslinked
protein–RNA complexes were resolved on a 4–12% Nu-
PAGE gel (Thermo-Fisher Scientific) and transferred to a
nitrocellulose membrane. Protein–RNA complex migrat-
ing at an expected molecular weight were excised, and
RNA by proteinase K (Roche) treatment and phenol–
chloroform extraction. Purified RNA was further ligated
to 5′ adapters, reverse transcribed and PCR amplified. The
amplified cDNA was sequenced on a NextSeq 500 device
(Illumina).
In vitro transcription, capping, and 2′-O methylation of re-
porter RNAs
Annotated 5′ UTRs for selected transcripts were cloned
upstream of Renilla Luciferase (RLuc) under the control
of a T7 promoter, with 60 adenosine nucleotides down-
stream of the stop codon to mimic polyadenylation. 5′
UTR sequences are in Supplementary Table S4. Untrans-
lated regions were cloned using synthetic DNA (Integrated
DNA Technologies) or by isolation using 5′ RACE (RLM-
RACE kit, Invitrogen). Template was PCR amplified using
Phusion polymerase from the plasmids using the following
primers, and gel purified, as described (42).
pA60 txn rev: TTT TTT TTT TTT TTT TTT TTT TTT
TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT
TTT CTG CAG
pA60 txn fwd: CGG CCA GTG AAT TCG AGC TCT
AAT ACG ACT CAC TAT AGG
100 l in vitro transcription reactions were set up at
room temperature with 1–5 g of purified template, 7.5 mM
ACGU ribonucleotides, 30 mM Tris–Cl pH 8.1, 125 mM
MgCl2, 0.01% Triton X-100, 2 mM spermidine, 110 mM
DTT, T7 polymerase and 0.2 U/l units of Superase-In
RNase inhibitor (Thermo-Fisher Scientific). Transcription
reactions were incubated in a PCR block at 37◦C for 1 h. 1
l of 1 mg/ml pyrophosphatase (Roche) was added to each
reaction, and the reactions were subsequently incubated in
a PCR block at 37◦C for 3 h. 1 unit of RQ1 RNase-free
DNase (Promega) was added to each reaction followed by
further incubation for 30 minutes. RNA was precipitated
by the addition of 200 l 0.3 M NaOAc pH 5.3, 15 g Gly-
coBlue co-precipitant (Thermo-Fisher Scientific) and 750
l 100% EtOH. Precipitated RNA was further purified over
the RNA Clean & Concentrator-25 columns (Zymo Re-
search). Glyoxal gel was run to assess the integrity of the
RNA before subsequent capping and 2′ O-methylation.
20 g of total RNA was used in a 40 l capping reaction
with 0.5mM GTP, 0.2 mM S-adenosylmethionine (SAM),
20 units of Vaccinia capping enzyme (New England Bio-
labs), 100 units of 2′-O-Me-transferase (New England Bio-
labs) and 25 units RNasin Plus RNase inhibitor (Promega).
The reactions were incubated at 37◦C for 1 h, followed
by purification over the RNA Clean & Concentrator-25
columns (Zymo Research) and elution in DEPC H2O. Gly-
oxal gel was run to assess the integrity of the RNA before
proceeding to in vitro translation reactions.
Transfection of siRNA for in vitro translation
HEK 293T cells in 150mM plates were transfected with 20
l of siRNA (against DDX3 or a non-targeting control; se-
quences in Supplementary Table S5) using Lipofectamine
2000 (Thermo Fisher Scientific), following manufacturer’s
instructions. Cells were harvested for preparation of cellu-
lar extracts after 48 h.
Generation of DDX3 mutant translation extracts
DDX3 WT and R326H mutant constructs were synthesized
and cloned downstream of a CMV promoter (Twist Bio-
sciences). 40 g of plasmids were transfected into HCT
116 cells using Lipofectamine 2000 (Thermo Fisher Sci-
entific), following manufacturer’s instructions. Cells were
treated with 500 M indole-3-acetic acid (IAA) 24 h post-
transfection and harvested for preparation of cellular ex-
tracts after a further 48 h.
Preparation of cellular extracts for in vitro translation
Three to five 150 mm plates of HEK 293T or HCT 116 cells
were trypsinized and pelleted at 1000g, 4◦C. One cell-pellet
volume of lysis buffer (10 mM HEPES, pH 7.5, 10 mM
KOAc, 0.5 mM MgOAc2, 5 mM DTT, and 1 tablet Com-
plete mini EDTA free protease inhibitor (Sigma) per 10 ml)
was added to the cell pellet and was incubated on ice for
45 min. The pellet was homogenized by trituration through
a 26G needle attached to a 1 ml syringe 13–15 times. Ef-
ficiency of disruption was checked by trypan blue staining
(>95% disruption target). The lysate was cleared by cen-
trifugation at 14000g for 1 min at 4◦C, 2–5 l was reserved
for western blot analysis, and the remainder was aliquoted
and flash frozen in liquid nitrogen.
Antibodies
Primary antibodies used in this study include anti-DDX3
(Bethyl A300-474A; Figure 1), rabbit polyclonal anti-
DDX3 (custom made by Genemed Synthesis using pep-
tide ENALGLDQQFAGLDLNSSDNQS; Figure 5; (26)),
anti-actin HRP (Santa Cruz Biotechnology, sc-47778), anti-
FLAG HRP (Sigma, A8592).
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In vitro translation
5 l in vitro translation reactions were set up with 2.5
l of lysate and 20 ng total RNA (0.84 mM ATP, 0.21
mM GTP, 21 mM creatine phosphate, 0.009 units/ml crea-
tine phosphokinase, 10 mM HEPES pH 7.5, 2 mM DTT,
2 mM MgOAc, 100 mM KOAc, 0.008 mM amino acids,
0.25 mM spermidine, 5 units RNasin Plus RNase in-
hibitor (Promega) as described (48). Reaction tubes were
incubated at 30◦C for 45 min, and expression of the re-
porter was measured using the Renilla Luciferase Assay
System (Promega) on a GloMax Explorer plate reader
(Promega).
In cell translation
DDX3X-mAID tagged HCT-116 cells expressing OsTIR1
were plated into 96-well plates at ∼80% confluency. Cells
were pre-treated with DMSO or 500 M indole 3-acetic
acid (IAA) for 48 h. Cells were transfected with a mixture
of 10 ng in vitro transcribed firefly luciferase RNA with a
minimal 5′ UTR (FLuc) and between 50–200 ng renilla lu-
ciferase RNA (RLuc) downstream of selected 5′ UTRs us-
ing the TransIT mRNA Transfection Kit (Mirus Bio) per
manufacturer’s instructions. Twenty-four hours post trans-
fection, cells were lysed and expression of the reporters
were measured using the Dual-Luciferase Reporter As-
say System (Promega) on a GloMax Explorer plate reader
(Promega). The Renilla Luciferase signal in each well was
normalized to the Firefly Luciferase signal to control for
cell number, transfection efficiency, and basal translation
levels.
RESULTS
Identifying mRNAs that depend on DDX3 for efficient trans-
lation
We performed ribosome profiling and RNA-seq to deter-
mine the set of transcripts that are affected by depletion
of DDX3. DDX3X is an essential gene (26,49), so we tran-
siently knocked down its expression using siRNA and col-
lected ribosome protected footprints in duplicate experi-
ments (Figure 1A, B, Supplementary Figure S1A). Knock-
down efficiencies were ∼90% and ∼70% in replicates (Fig-
ure 1B). Measuring changes in both RNA abundance and
ribosome occupancy enabled us to distinguish between dif-
ferent modes of DDX3-mediated regulation. We found that
depletion of DDX3 affects ribosome occupancy of a mi-
nority of messages (Figure 1C). Most changes in ribosome
occupancy upon DDX3 depletion were decreases, broadly
suggesting that the function of DDX3 is to increase ri-
bosome occupancy. Genes such as DVL2, NT5DC2 and
ODC1, which is described to be translationally-controlled
(50), decreased in ribosome occupancy upon DDX3 deple-
tion (Figure 1C, D, Supplementary Table S1). Diverse bio-
logical pathways were affected by DDX3 depletion, reveal-
ing the enrichment of histone mRNAs among the few exam-
ples of translationally upregulated transcripts, which might
reflect a resistance to a widespread translation suppression
rather than an increase in protein synthesis. Genes related to
neuronal branching belonged to the translationally down-
regulated set (Supplementary Figure S1B). To confirm the
effects of DDX3 depletion on the translated transcriptome,
we also established a cell line to rapidly and efficiently de-
grade endogenous DDX3 in human male-derived colorec-
tal cancer HCT 116 cells, a near-diploid cell line amenable
to genome engineering, upon addition of auxin (Supple-
mentary Figure S2A; (51). As with the siRNA knockdown,
induced degradation of DDX3 predominantly resulted in
a marked decrease in the translation of a subset of cellu-
lar messages (Supplementary Figure S2B). Translation ef-
ficiency (TE) changes were more similar than steady state
RNA levels upon siRNA knockdown or chemical degrada-
tion (Supplementary Figure S2C, Supplementary Table S1),
even though these experiments were performed in different
cell lines (HEK 293T versus HCT 116) and with different
depletion approaches, affirming DDX3 function in transla-
tion regulation.
Our data suggest that DDX3 directly affects translation
of a subset of mRNAs. However, ribosome profiling mea-
sures ribosome density, which can be affected by changes to
translation initiation, translation elongation, or ribosome
stalling. DDX3 is thought to regulate translation through
transcript 5′ UTRs, and we found genes that are regu-
lated by their 5′ UTRs such as ODC1 in the translation-
ally downregulated set (Figure 1C; (50,52). To test whether
altered translation initiation contributes to the impact of
DDX3 knockdown on ribosome density, we cloned DDX3-
sensitive 5′ UTRs from this and previous work (3,25,53) up-
stream of a Renilla luciferase reporter and compared them
to a control reporter that is not sensitive to DDX3 deple-
tion. Since DVL2 has many annotated 5′ UTRs that over-
lap, we cloned the prevalent isoforms in HEK 293T cells
using 5′ RACE, which yielded a short and long isoform
(Materials and Methods). We then made translation ex-
tracts from HEK 293T cells transfected with a nontarget-
ing control siRNA or a DDX3 siRNA (Figure 1E). Next,
reporter RNAs were in vitro transcribed, capped, and 2′-
O methylated and used for in vitro translation in wild-type
or DDX3-depleted lysate. We found that the 5′ UTRs from
the DDX3-sensitive mRNAs ODC1, PRKRA, RAC1 and
DVL2 also conferred DDX3 dependence to the luciferase
reporter (Figure 1F). However, other reporter RNAs, such
as ATF5 or and RPLP1, did not change in the in vitro
translation upon DDX3 knockdown. RPLP1 was identi-
fied as an mRNA with uORF occupancy changes upon
mutant DDX3 expression in prior work (3), while ATF5
was previously implicated in DDX3-dependent translation
(25,53). To compare in vitro translation with translation
in cellular contexts, we transfected the same reporter mR-
NAs into HCT 116 cells with DDX3 depleted using our
degron system (Figure 1G, Supplementary Figure S2D).
The results of the in vitro and cellular translation assays
show a high degree of concordance, with the exception of
the CCNE1 5′UTR, which was previously shown to re-
quire DDX3 for efficient translation (25). Therefore, based
on these reporter experiments, we interpret ribosome occu-
pancy changes upon DDX3 depletion as a result of mis-
regulated translation initiation dynamics and refer to them
as translation efficiency (TE).














































































































































































Figure 1. Translational changes upon DDX3 depletion. (A) A workflow of the ribosome profiling experiments. (B) siRNA knockdown efficiency of DDX3
analyzed by western blot. Mock: untreated. NTC: nontargeting control siRNA. (C) The log2 fold change (log2FC) in ribosome profiling or RNA levels
are plotted for all genes. Number genes in each category are indicated with selected genes labeled. Point size indicates the P-value of a significant change in
translational efficiency. (D) Tracks showing RNA-seq (RNA) or ribosome profiling (RP) reads that map to the NT5DC2 mRNA. NT5DC2 is an mRNA
with differential ribosome occupancy in (C). (E) Western blot analysis of nontargeting (siNTC) or siDDX3 translation lysate samples with antibodies
indicated. (F) Renilla luciferase luminescence from in vitro transcribed reporter RNAs translated in vitro in siNTC or siDDX3 HEK 293T lysates. (G)
Reporter RNAs as in (F) transfected into HCT 116 cells with or without IAA treatment to induce the DDX3 degron.
Defining the features that mediate DDX3-dependent transla-
tion
The in vitro and cellular translation experiments implicated
translation initiation and transcript 5′ UTRs in mRNAs
that are sensitive to DDX3 depletion. To determine which
features contribute to quantitative changes in translation
upon knockdown of DDX3, we used known translational-
control elements to generate a random forest regression
model. A model with 28 features (Materials and Methods)
was able to moderately predict the translation changes upon
DDX3 knockdown (correlation between predicted and ob-
served changes = 0.54, Supplementary Figure S3A), with
few features driving the model performance (Figure 2A,
Materials and Methods), such as baseline translation lev-
els, GC content in coding sequences and 5′ UTRs, and den-
sity of the CERT motif. The CERT motif is a cytosine-
rich element that has been implicated in eIF4E- and eIF4A-
dependent translation through incompletely understood
mechanisms (54,55). Interestingly, mRNAs that are sensi-
tive to DDX3 depletion appear to be poorly translated in
HEK 293T cells (Figure 2B). A reduced random forest re-
gression model only using the four most relevant features





Figure 2. DDX3-sensitive transcripts have complex 5′ leaders. (A) Strength of individual random forest model features that predict TE with R = 0.54
(Supplementary Figure S2A, Materials and Methods). Features in blue are plotted in (B). (B) The translation efficiency (TE) in wild-type cells, CERT
motif score, GC-content of 5′ UTRs, and GC content of coding sequences in the indicated gene sets from Figure 1C were computed and are plotted as
a density plot based on their importance in the random forest model. Vertical lines are medians. P-values for Wilcoxon rank sum and effect sizes from
Cliff ’s delta (d) versus mixed ns indicated. (C) The fold-change of the ratio in ribosome occupancy in the 5′ UTR versus the coding sequence upon DDX3
depletion as a density plot for transcripts in the indicated sets. A larger 5′ UTR skew value means that there are more ribosomes in the 5′ UTR compared
to the coding sequence. P-values from Wilcoxon rank sum and effect sizes from Cliff ’s delta (d) versus mixed ns indicated. (D) An example gene (HMBS)
with increases in 5′ UTR ribosomes versus coding sequence ribosomes with tracks as in Figure 1D.
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performed similarly; conversely, a model built without us-
ing sequence predictors or baseline translation levels could
not recapitulate translation downregulation effects (Supple-
mentary Figure S3B, S3C). 5′ UTR and coding sequence
GC content may be indications of increased RNA structure
in these regions, possibly relevant for other aspects of cyto-
plasmic RNA processing (Discussion).
To test the ability of the random forest to select relevant
features predictive of DDX3-mediated translation changes,
we compared it to lasso regression, another method used
to perform feature selection among a set of correlated pre-
dictors (Materials and Methods). The two methods largely
agreed in pinpointing relevant features, with the random
forest slightly outperforming the lasso (Supplementary Fig-
ure S3D, E). The features predicted to drive DDX3 sensitiv-
ity also showed different distributions among the regulated
mRNAs, especially in the translationally downregulated set,
indicating that the features identified by the random forest
are indeed different between sets of transcripts (Figure 2B).
We measured the enrichment of ribosomes in transcript 5′
UTRs, under the hypothesis that depletion of DDX3 might
lead to defective scanning and ribosome accumulation (1),
or selective ribosome depletion on coding sequences. In-
deed, we found more ribosomes in transcript 5′ UTRs rel-
ative to coding sequences upon DDX3 depletion (Figure
2C), especially in mRNAs that show translational down-
regulation. As an example, HMBS ribosome occupancy is
shown in Figure 2D, which showed changes in ribosome
density in its 5′ UTR and therefore may be regulated by up-
stream ORF (uORF) translation.
DDX3 crosslinks to ribosomal RNA and 5′ UTRs
The above ribosome profiling and RNA-seq experiments
identified the set of transcripts that are affected by DDX3
depletion, but these transcripts could be affected by direct
or indirect mechanisms. Therefore, to better define the set
of transcripts that are direct targets of DDX3, we measured
DDX3 binding sites with high specificity using PAR-CLIP
(Figure 3A, Supplementary Figure S1A). Previous work us-
ing a complementary method (iCLIP) to measure DDX3
binding sites identified 5′ UTR and ribosomal RNA bind-
ing. Curiously, even though DDX3 is thought to regulate
translation initiation, binding was also identified in coding
sequences and 3′ UTRs (3,12). Here, we used the additional
specificity afforded by T>C transitions induced by protein
adducts on crosslinked uridine residues in PAR-CLIP to re-
fine DDX3 binding sites across the transcriptome (46).
High-throughput sequencing of RNA fragments
crosslinked to DDX3 identified a binding site for DDX3
on the 18S ribosomal RNA (Figure 3B; visualized on the
structure (56). It is possible that these rRNA reads could
arise from nonspecific interactions between RNA binding
proteins and the highly abundant rRNA. However, while
there were many rRNA fragments sequenced following
PAR-CLIP, there was only one site with high-confidence
T>C transitions, spanning nucleotides 527–553 in the 18S
rRNA (Figure 3B, Supplementary Figure S4A). This site
maps to helix 16 of the 18S rRNA, similar to where Ded1
crosslinks to 18S rRNA in yeast, and does not contain
post-transcriptionally modified rRNA nucleotides (1,57).
Helix 16 (h16) is on the small ribosomal subunit facing
incoming mRNA, which might provide DDX3 access to
resolve mRNA secondary structures to facilitate inspection
by the scanning 43S complex (Figure 3C). The crosslink
site on h16 is just opposite an RRM domain that has
been assigned as eIF4B, another factor crucial in ribosome
recruitment and scanning (56,58,59). This is consistent with
observations that eIF4B and Ded1 cooperate in translation
initiation on mRNAs (58). Recently, it has been proposed
that this RRM domain may belong to eIF3g, another
translation initiation factor (60), which is consistent with a
reported interaction between eIF3 and DDX3 (26).
In addition to ribosomal RNA binding, we found that
DDX3 interacts primarily with coding transcripts (Figure
4A, Supplementary Table S2). To identify where DDX3
binds mRNAs, we aggregated peaks across all expressed
transcripts in a metagene analysis. We found that DDX3
primarily contacts transcript 5′ UTRs, with a small num-
ber of reads mapping in the coding sequence and 3′ UTR
(Figure 4B). A large peak was also observed at the start
codon, which could reflect kinetic pausing during subunit
joining while DDX3 is still bound to the initiating ribosome
(61). We used available CLIP data to compare the binding
pattern of DDX3 to other known mRNA-binding proteins
(39). We selected three RNA-binding proteins to compare
to: eIF3b is a member of the multi-subunit initiation factor
eIF3 (62), FMR1 interacts with elongating ribosomes (63),
and MOV10 is involved in 3′ UTR-mediated mRNA decay
(64,65). The binding pattern of DDX3 most closely resem-
bles the initiation factor eIF3b (Figure 4B). We detected
some DDX3 binding within coding sequences and even 3′
UTRs, which could arise from background signal, or al-
ternative binding modes. PAR-CLIP indicated that DDX3
binds abundant mRNAs (Supplementary Figure S4B), in-
cluding ribosomal protein genes. While this observation can
provide insights into the molecular functions of DDX3, it
might reflect a limit in the sensitivity of our PAR-CLIP
data. Therefore, we decided to investigate PAR-CLIP bind-
ing patterns which are not strongly confounded by expres-
sion levels. We used the frequency of T>C transitions at
each site as a measure of the specificity of protein-RNA
interactions (66). High specificity crosslinks with frequent
T>C transitions resided most often in 5′ UTRs (Figure 4C),
as also shown in a translationally-regulated transcript such
as ODC1 (Figure 4D). Confirmation of this binding pattern
comes from an independent assay of protein–RNA interac-
tion, as measured by enhanced CLIP (eCLIP) (Supplemen-
tary Figure S4C; 67).
Next, we sought to describe the mRNA regions with en-
riched DDX3 binding. DEAD-box RNA helicases engage
RNA by recognizing structural elements with poorly de-
fined sequence context (68), which hinders the ability to
extract meaningful sequence motifs from CLIP data. To
investigate this phenomenon, we performed de novo mo-
tif finding on PAR-CLIP peaks in HEK 293 cells from the
POSTAR2 repository (39; Materials and Methods). As ex-
pected, motifs extracted from different RBPs showed dif-
ferent degrees of specificity (Supplementary Figure S4D).
DDX3 motifs, together with motifs from translation initi-
ation factors and other ribosome interactors, showed poor
significance when compared to other RBPs with more de-
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Figure 3. DDX3 binding sites on rRNA identified by PAR-CLIP. (A) A workflow of the PAR-CLIP experiment. (B) PAR-CLIP T>C conversion locations
on human rDNA (top) compared to iCLIP coverage from Oh et al. 2016 (bottom). Boxed regions refer to processed rRNA transcripts. (C) PAR-CLIP
T>C conversion density on the 18S rRNA is visualized from gray to blue on the structure of the 48S ribosome (PDB 6FEC). The peak in (B) is contained
in the helix in the upper left in (C), which is h16 of rRNA. Yellow: translation factors; blue–gray: rRNA; pink: ribosomal proteins.
fined sequence specificity (such as members of cleavage
and polyadenylation machinery, or known 3′UTR binders).
This result called for a more targeted analysis of DDX3
binding sites. By investigating the sequence-structure con-
text around mRNA peaks in 5′ UTRs, we observed that
DDX3 binding sites by PAR-CLIP reside in highly struc-
tured regions (Figure 4E). We observed a higher guanine
content (accompanied by predicted G-quadruplexes; Sup-
plementary Figures S4E, F) upstream of the binding site;
downstream of the peak summit, we detected high GC
content resembling the CERT motif (Figure 4F), a regula-
tory motif highly predictive of DDX3-mediated translation
regulation (Figure 2A). Moreover, we observed increased
T>C conversion specificity in the 5′ UTR of transcripts
whose translation decreases upon DDX3 depletion (Fig-
ure 4G), indicative of a possibly stronger protein-RNA as-
sociation at those regions. This binding pattern, combined
with the observation that DDX3 co-fractionates with both
polysomes and initiation complexes, suggests that DDX3
acts with the 40S during the process of translation initia-
tion (2,69–71). Taken together, we conclude that the DDX3
binds and regulates the translation of poorly translated mR-
NAs exhibiting complex sequence-structure features in their
5′UTRs.
Identifying translation changes caused by DDX3 mutations
De novo genetic variants in DDX3X cause developmental
delay and intellectual disability in DDX3X-syndrome (13–
16). Interestingly, patients carrying inactivating point muta-
tions in DDX3 display more severe clinical symptoms than
patients with truncating mutations (16). Point mutations in
DDX3 associated with medulloblastoma are dominant neg-
ative and act by preventing enzyme closure of DDX3 to-
wards the high-RNA-affinity ATP-bound state (6–11). This
suggests there may be different effects on translation be-
tween depletion of DDX3 and inhibition or expression of
an inactive mutant.
To test the effect of mutants in DDX3 on translation,
we transfected cells with plasmids containing wild-type or
mutant DDX3 proteins after auxin-induced degradation of
endogenous DDX3, switching expression from the wild-
type sequence to an allele of interest (Figure 5A). We used
this system to define acute changes to translation caused
by DDX3 mutations without allowing the cells to adapt
to the presence of inactive DDX3 alleles, which may also
be lethal. We measured genome-wide translation changes
caused by DDX3 mutants using ribosome profiling (Sup-
plementary Table S1). A collection of genes related to the
double-stranded DNA response were upregulated at the
level of RNA abundance, likely due to differences in trans-
fected DNA amounts (Figure 5B, upper right). Broadly,
we noticed higher variability in in ribosome occupancy
changes (Figure 5B, y-axis) than RNA level changes (Fig-
ure 5B, x-axis) when compared to the siDDX3 experiments
(Figure 1C), suggesting that one functional difference be-
tween mutant and knockdown might involve regulation of
RNA steady-state levels. Among the few regulated mRNAs,
we observed a robust downregulation of ODC1 transla-
tion, which was directly bound by DDX3 (Figure 4D) and
strongly downregulated in the DDX3 depletion experiment
(Figure 1C).
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Figure 4. DDX3 binds to structured 5′ leaders of mRNA. (A) Sum of the DDX3 PAR-CLIP peaks mapping on different gene types and regions. (B)
A metagene plot of DDX3 PAR-CLIP across all genes and PAR-CLIP data from other RNA binding proteins. eIF3b is a canonical initiation factor,
FMR1 binds elongating ribosomes, and MOV10 is a 3′ UTR binding factor. TSS: transcription start site, TES: transcription end site. (C) T>C conversion
specificity averaged across all PAR-CLIP peaks across indicated mRNA regions as in (B). (D) PAR-CLIP, ribosome profiling, and RNA-seq across part of
the ODC1 gene. Blue peaks in the PAR-CLIP track indicate T>C conversion events. (E) RNA structure in a window of 100 nucleotides around PAR-CLIP
peak summits in 5′ UTRs. (F) CERT motif scores averaged across PAR-CLIP peak summits in 5′ UTRs or for shuffled positions. (G) PAR-CLIP T>C
conversion specificity in transcript regions in indicated gene sets from Figure 1.






Figure 5. Translation changes caused by R326H mutant DDX3. (A) Western blots of degron DDX3 cells treated with IAA and transfected with empty
vector or the indicated constructs. (B) Ribosome profiling and RNA-seq of DDX3 degron cells treated with IAA and transfected with either DDX3 wild-
type or R326H mutant. (C) Western blots of cells treated with siDDX3 and transfected with the indicated constructs. (D) In vitro translation performed
with indicated reporter RNAs as in Figure 1 in the lysates from panel (C). Reporter sequences are in Supplementary Table S4.
To further test the difference between knockdown and
mutant DDX3 at the level of individual 5′ UTRs, we made
in vitro translation extracts with wild-type DDX3, R326H
DDX3, or R534H DDX3 and measured translation of
a panel of reporters (Figure 5C; (3)). Broadly, we found
two classes of reporter RNAs (Figure 5D; Supplemen-
tary Figure S5A, B). One class, including ODC1, PRKRA,
RAC1 and DVL2 isoforms decreased in translation in all
tested perturbations to DDX3. Another class, including
ATF5, CCNE1 and RPLP1 selectively decreased in trans-
lation in mutant DDX3 extracts but not in knockdown ex-
tracts. We sought to test chemical inhibition of DDX3, as
it functionally mimics a dominant negative mutation by
blocking ATP binding. We were unable to inhibit transla-
tion in a DDX3-dependent manner using RK-33 (72), and
instead found that it acted as a general translation inhibitor
(Supplementary Figure S5C). Taken together, we found that
DDX3 sensitivity for translation is preserved in translation
extracts and that depletion of DDX3 appears to have dif-
ferent outcomes on translation than inhibition or dominant
negative variants.
DISCUSSION
DDX3X is an essential human gene that is altered in diverse
diseases. Here, we use a set of transcriptomics approaches,
machine learning and biochemistry to show that DDX3 reg-
ulates a subset of the human transcriptome, likely through
resolving RNA structures in 5′UTRs (Figure 6). Reporter
experiments show that 5′ UTRs are sufficient to confer
DDX3 sensitivity onto unrelated coding sequences. We con-
clude that DDX3 affects translation initiation through tran-
script 5′ UTRs. Our data suggest that the major role of
DDX3 is in translation initiation and reveal translation dif-
ferences between mutated and haploinsufficient DDX3 ex-
pression.
We identified binding between DDX3 and helix 16 (h16)
on the human 40S ribosome. This is similar to binding
sites identified previously using other CLIP approaches
(1,3,12), confirmed here using T>C transitions defined
by PAR-CLIP. Interestingly, histone mRNAs showed sus-
tained translation levels upon DDX3 knockdown (Figure
1C). However, histone mRNAs represent a peculiar cate-
gory of transcripts, often containing short UTRs, few in-
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Figure 6. A model of DDX3 in translational control. DDX3 binds to the small subunit via helix 16 (h16). Transcripts that are poorly translated in normal
cells and that harbor increased intramolecular RNA structure (blue transcript; left) are sensitive to DDX3 depletion (right). Other mRNAs that are initially
highly translated (black transcript) are unaffected.
trons, highly repetitive sequences and the lack a poly-A
tail. The quantitative contribution of some of these features
have been resolved by our regression approach, with good
agreement between the lasso and the random forest mod-
els. However, we believe that more tailored approaches are
needed to precisely investigate regulation of specific classes
of mRNAs. For instance, histone mRNA translation has
been recently shown to be dependent on mRNA binding to
the rRNA h16 helix (73). Our data suggests that there might
be competition for h16 between DDX3 and histone mR-
NAs, and their translation increases upon DDX3 knock-
down due to increased accessibility to h16. The set of mR-
NAs that require h16 for their translation will be an inter-
esting direction to pursue in the future.
Despite primarily affecting translation, some genes ex-
hibited changes in steady-state RNA abundance upon
DDX3 depletion. RNA-level changes could be mediated
by indirect effects of a DDX3-dependent translation target,
or reflect additional mechanisms of post-transcriptional
gene regulation, possibly mediated by RNA structural fea-
tures, codon composition, or other RNA decay pathways
(74). Moreover, DDX3 is an important factor in stress-
granule complexes (75), and possibly involved in granule-
specific regulation of mRNA metabolism. Interestingly, we
observed more RNA-level changes in DDX3-depletion ex-
periments (Figure 1C and Supplementary Figure S2B) than
in experiments using a mutation in DDX3 (Figure 5B). Po-
tential interactions between DDX3 regulation of both ribo-
some occupancy and RNA levels will be further explored in
future studies.
DDX3 is an abundant protein, with approximately 1.4
million copies per HeLa cell (76), or about half the abun-
dance of ribosomes (77). We have interpreted data in this
work by hypothesizing that DDX3 is functioning in cis by
binding to the 40S ribosome and facilitating translation ini-
tiation on the associated mRNA (Figure 6). It is also possi-
ble that DDX3, alone or in combination with other DEAD-
box proteins like eIF4A, functions in trans by activating an
mRNA prior to 43S complex loading. Future work defin-
ing the binding site of DDX3 on the ribosome could enable
separation of cis and trans functions to test these two mod-
els, although we note that the functional consequences of
DDX3 depletion we have observed here are independent of
its functioning in cis or trans.
DDX3 is altered in numerous human diseases, includ-
ing cancers and developmental disorders (5). Some diseases
are characterized by missense variants (8–11), while oth-
ers involve predominantly nonsense or frameshift variants
(17,18), and still others present with a mixture of variant
types (13–16). Our work suggests that variants in DDX3
that deplete protein levels may result in different translation
changes than inactivating missense variants. We attempted
to directly compare translational changes upon DDX3 de-
pletion identified in this work with previous expression of
mutant DDX3 but stopped due to confounding variabil-
ity in biological sample and library preparation and se-
quencing protocols. Defining how different mutation types
in DDX3 affect gene expression, the underlying molecular
mechanisms, and potential therapeutic interventions is an
intriguing direction for the future.
DATA AVAILABILITY
Processed datasets and code to reproduce the main
figures can be found here: https://github.com/lcalviell/
DDX3X RPCLIP.
Sequencing data can be retrieved using GEO accession
numbers GSE125114 and GSE157063.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
5348 Nucleic Acids Research, 2021, Vol. 49, No. 9
ACKNOWLEDGEMENTS
We thank members of the Floor lab for feedback on the
manuscript. Computation was supported by the UCSF
Wynton computing infrastructure.
Author contributions: Conceptualization, L.C., E.W., W.F.,
M.L. and S.N.F.; Investigation, L.C., K.R., S.V., K.W. and
E.W.; Writing – Original Draft, S.N.F.; Writing – Review &
Editing, S.N.F., S.V., L.C., E.W. and M.L.; Resources, B.T.,
M.T., J.K. and W.F.; Funding Acquisition, M.L. and S.N.F.;
Supervision, W.F., M.L. and S.N.F.
FUNDING
University of California, San Francisco Program for Break-
through Biomedical Research, Sandler Foundation [to
S.N.F., in part]; California Tobacco-Related Disease Re-
search Grants Program [27KT-0003 to S.N.F., T30DT1004
to K.W.]; National Institutes of Health [DP2GM132932
to S.N.F., F32GM133144 to S.V.]; DFG Priority Project
[SPP1935 to K.R. and M.L.]. Funding for open access
charge: Research grants.
Conflict of interest statement. S.N.F. consults for MOMA
Therapeutics.
REFERENCES
1. Guenther,U.-P., Weinberg,D.E., Zubradt,M.M., Tedeschi,F.A.,
Stawicki,B.N., Zagore,L.L., Brar,G.A., Licatalosi,D.D., Bartel,D.P.,
Weissman,J.S. et al. (2018) The helicase Ded1p controls use of
near-cognate translation initiation codons in 5′ UTRs. Nature, 559,
130.
2. Lai,M.-C., Lee,Y.-H.W., Tarn,W.-Y. and Walter,P. (2008) The
DEAD-Box RNA helicase DDX3 associates with export messenger
ribonucleoproteins as well as tip-associated protein and participates
in translational control. Mol. Biol. Cell, 19, 3847–3858.
3. Oh,S., Flynn,R.A., Floor,S.N., Purzner,J., Martin,L., Do,B.T.,
Schubert,S., Vaka,D., Morrissy,S., Li,Y. et al. (2016)
Medulloblastoma-associated DDX3 variant selectively alters the
translational response to stress. Oncotarget, 7, 28169–28182.
4. Soto-Rifo,R., Rubilar,P.S., Limousin,T., Breyne,S., Décimo,D. and
Ohlmann,T. (2012) DEAD-box protein DDX3 associates with eIF4F
to promote translation of selected mRNAs. EMBO J., 31, 3745–3756.
5. Sharma,D. and Jankowsky,E. (2014) The Ded1/DDX3 subfamily of
DEAD-box RNA helicases. Crit. Rev. Biochem. Mol. Biol., 49,
343–360.
6. Epling,L.B., Grace,C.R., Lowe,B.R., Partridge,J.F. and Enemark,E.J.
(2015) Cancer-associated mutants of RNA helicase DDX3X are
defective in RNA-stimulated ATP hydrolysis. J. Mol. Biol., 427,
1779–1796.
7. Floor,S.N., Condon,K.J., Sharma,D., Jankowsky,E. and
Doudna,J.A. (2016) Autoinhibitory interdomain interactions and
subfamily-specific extensions redefine the catalytic core of the human
DEAD-box protein DDX3. J. Biol. Chem., 291, 2412–2421.
8. Jones,D.T., Jager,N., Kool,M., Zichner,T., Hutter,B., Sultan,M.,
Cho,Y.J., Pugh,T.J., Hovestadt,V., Stutz,A.M. et al. (2012) Dissecting
the genomic complexity underlying medulloblastoma. Nature, 488,
100–105.
9. Kool,M., Jones,D.T., Jager,N., Northcott,P.A., Pugh,T.J.,
Hovestadt,V., Piro,R.M., Esparza,L.A., Markant,S.L., Remke,M.
et al. (2014) Genome sequencing of SHH medulloblastoma predicts
genotype-related response to smoothened inhibition. Cancer Cell, 25,
393–405.
10. Pugh,T.J., Weeraratne,S.D., Archer,T.C., Pomeranz Krummel,D.A.,
Auclair,D., Bochicchio,J., Carneiro,M.O., Carter,S.L., Cibulskis,K.,
Erlich,R.L. et al. (2012) Medulloblastoma exome sequencing
uncovers subtype-specific somatic mutations. Nature, 488, 106–110.
11. Robinson,G., Parker,M., Kranenburg,T.A., Lu,C., Chen,X., Ding,L.,
Phoenix,T.N., Hedlund,E., Wei,L., Zhu,X. et al. (2012) Novel
mutations target distinct subgroups of medulloblastoma. Nature, 488,
43–48.
12. Valentin-Vega,Y.A., Wang,Y.-D., Parker,M., Patmore,D.M.,
Kanagaraj,A., Moore,J., Rusch,M., Finkelstein,D., Ellison,D.W.,
Gilbertson,R.J. et al. (2016) Cancer-associated DDX3X mutations
drive stress granule assembly and impair global translation. Sci. Rep.,
6, 25996.
13. Deciphering Developmental Disorders, S. (2015) Large-scale
discovery of novel genetic causes of developmental disorders. Nature,
519, 223–228.
14. Snijders Blok,L., Madsen,E., Juusola,J., Gilissen,C., Baralle,D.,
Reijnders,M.R., Venselaar,H., Helsmoortel,C., Cho,M.T.,
Hoischen,A. et al. (2015) Mutations in DDX3X are a common cause
of unexplained intellectual disability with gender-specific effects on
Wnt signaling. Am. J. Hum. Genet., 97, 343–352.
15. Wang,X., Rosenfeld,J.A., Bacino,C.A., Scaglia,F., Immken,L.,
Harris,J.M., Hickey,S.E., Mosher,T.M., Slavotinek,A., Zhang,J. et al.
(2018) Phenotypic expansion in DDX3X –– a common cause of
intellectual disability in females. Ann. Clin. Transl. Neurol., 5,
1277–1285.
16. Lennox,A.L., Hoye,M.L., Jiang,R., Johnson-Kerner,B.L., Suit,L.A.,
Venkataramanan,S., Sheehan,C.J., Alsina,F.C., Fregeau,B.,
Aldinger,K.A. et al. (2020) Pathogenic DDX3X mutations impair
RNA metabolism and neurogenesis during fetal cortical
Developmentd Neuron, 106, 404–420.
17. Dufva,O., Kankainen,M., Kelkka,T., Sekiguchi,N., Awad,S.A.,
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